LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Preventing postpartum hemorrhage: A network meta-analysis on routes of administration of uterotonics.

    Papadopoulou, Argyro / Tournas, Georgios / Georgiopoulos, Georgios / Antsaklis, Panos / Daskalakis, Georgios / Coomarasamy, Arri / Devall, Adam J

    European journal of obstetrics, gynecology, and reproductive biology

    2024  Volume 295, Page(s) 172–180

    Abstract: 1.: Objective: To perform a network meta-analysis to specify the route of administration that maximises the effectiveness of each of the available prophylactic uterotonics without increasing the risk for side effects. 2.: Data sources: Literature ... ...

    Abstract 1.
    Objective: To perform a network meta-analysis to specify the route of administration that maximises the effectiveness of each of the available prophylactic uterotonics without increasing the risk for side effects. 2.
    Data sources: Literature searches on 12th September 2022 included: CENTRAL, MEDLINE, Embase, CINAHL, ClinicalTrials.gov and the WHO International Clinical Trials Registry Platform. The reference lists of the retrieved study records were also searched. 3.
    Study eligibility criteria: Population: Randomized controlled trials involving women in the third stage of labour after a vaginal or caesarean delivery in hospital or community settings.
    Interventions: Systemically administered prophylactic uterotonics of any route and dose for primary postpartum hemorrhage prevention. Comparison: Any other prophylactic uterotonic, or a different route or dose of a given uterotonic, or placebo, or no treatment. Outcomes (primary): postpartum hemorrhage ≥ 500 mL and ≥ 1000 mL. 4.
    Study appraisal and synthesis methods: Risk of bias and trustworthiness assessments were performed, according to Cochrane's guidance. Direct, indirect and network meta-analyses were conducted, and results were summarized either as risk ratio or mean difference with 95% confidence intervals for dichotomous and continuous outcomes, respectively. The certainty of generated evidence was assessed according to the GRADE approach. Cumulative probabilities were calculated and the surface under the cumulative ranking curve was used to create a ranking of the available drugs. 5.
    Results: One hundred eighty-one studies involving 122,867 randomised women were included. Most studies were conducted in hospital settings in lower-middle income countries and involved women delivering vaginally. When compared with intramuscular oxytocin, carbetocin (RR 0.58, 95 % CI 0.40-0.84) and oxytocin (RR 0.75, 95 % CI 0.59-0.97) by an intravenous bolus, and intramuscular ergometrine plus oxytocin combination (RR 0.71, 95 % CI 0.56-0.91) are probably more effective in preventing primary postpartum hemorrhage. Intramuscularly administered oxytocin and carbetocin by an intravenous bolus have a favourable side effects profile. 6.
    Conclusions: Generated evidence was generally moderate and global inconsistency was low. Carbetocin and oxytocin by an intravenous bolus, and intramuscular ergometrine plus oxytocin combination are probably the top uterotonics for primary postpartum hemorrhage prevention. Large scale studies exploring different routes of administration for available prophylactic uterotonics, and women's views should be conducted.
    MeSH term(s) Pregnancy ; Female ; Humans ; Postpartum Hemorrhage/prevention & control ; Postpartum Hemorrhage/drug therapy ; Oxytocin ; Oxytocics ; Ergonovine/therapeutic use ; Network Meta-Analysis ; Labor Stage, Third ; Randomized Controlled Trials as Topic
    Chemical Substances Oxytocin (50-56-6) ; Oxytocics ; Ergonovine (WH41D8433D)
    Language English
    Publishing date 2024-02-14
    Publishing country Ireland
    Document type Meta-Analysis ; Journal Article ; Review
    ZDB-ID 190605-7
    ISSN 1872-7654 ; 0301-2115 ; 0028-2243
    ISSN (online) 1872-7654
    ISSN 0301-2115 ; 0028-2243
    DOI 10.1016/j.ejogrb.2024.02.021
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Assessment of frailty and related outcomes in older patients with heart failure: A cohort study.

    Tournas, Georgios / Kourek, Christos / Mantzaraki, Vassiliki / Georgiopoulos, Georgios / Pantos, Constantinos / Toumanidis, Savvas / Briasoulis, Alexandros / Paraskevaidis, Ioannis

    Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

    2022  Volume 67, Page(s) 42–47

    Abstract: Objective: Heart failure (HF) is a common cause of morbidity and mortality in older patients. Frailty is prevalent and complicates the course of HF. We sought to investigate the impact of frailty on HF outcomes.: Methods: Patients over 65 years old ... ...

    Abstract Objective: Heart failure (HF) is a common cause of morbidity and mortality in older patients. Frailty is prevalent and complicates the course of HF. We sought to investigate the impact of frailty on HF outcomes.
    Methods: Patients over 65 years old hospitalized with acute decompensated HF and mildly reduced or preserved EF, between September 2017 and September 2019 were enrolled in the study. Before hospital discharge at euvolemic state, patients underwent six-minute walk test (6MWT) and frailty assessment using FRIED and modified SOF scores. Predictors of death, readmissions, and increase in diuretic dose were analyzed by multivariable logistic regression models.
    Results: We enrolled 193 consecutive patients (mean age 78.6 ± 8.4 years, 29.5% males, 59.6% with HF and preserved EF). All patients had at least one comorbidity (40.9% coronary artery disease, 71% diabetes, and 86% hypertension). The mean 6MWT distance was 316.2 meters. According to FRIED score, 4.7% were normal and 17.6% were categorized as pre-frail and 77.7% as frail, while according to SOF index 9.8% were normal, 15% were categorized as pre-frail and 75.1% as frail. Frail patients according to both indices had a higher risk of 90-day readmissions, uptitration of diuretics within 90 days (p < 0.001 for both) and numerically but not significantly higher risk of death. Frailty status was independently associated with higher risk of 90-day readmissions, uptitration of diuretics, and higher BNP at 90 days.
    Conclusions: Frailty in older patients with HF is common and associated with worse prognosis. Pre-discharge frailty assessment may aid in identification of patients at high-risk for short-term complications.
    MeSH term(s) Aged ; Aged, 80 and over ; Cohort Studies ; Diuretics/therapeutic use ; Female ; Frailty/complications ; Frailty/epidemiology ; Heart Failure/complications ; Heart Failure/epidemiology ; Hospitalization ; Humans ; Male
    Chemical Substances Diuretics
    Language English
    Publishing date 2022-04-22
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2215027-4
    ISSN 2241-5955 ; 1109-9666
    ISSN (online) 2241-5955
    ISSN 1109-9666
    DOI 10.1016/j.hjc.2022.04.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Transcatheter mitral valve repair with MitraClip in patients with pulmonary hypertension: hemodynamic and prognostic perspectives.

    Mandurino-Mirizzi, Alessandro / Tua, Lorenzo / Arzuffi, Luca / Demarchi, Andrea / Somaschini, Alberto / Tournas, Georgios / Crimi, Gabriele / Androulakis, Emmanuel / Briasoulis, Alexandros / Cornara, Stefano

    Reviews in cardiovascular medicine

    2021  Volume 22, Issue 1, Page(s) 33–38

    Abstract: Transcatheter mitral valve repair with MitraClip has emerged as a possible therapeutic option for patients with severe mitral regurgitation (MR) with high risk for surgical valve repair. MitraClip intervention has demonstrated to improve haemodynamics ... ...

    Abstract Transcatheter mitral valve repair with MitraClip has emerged as a possible therapeutic option for patients with severe mitral regurgitation (MR) with high risk for surgical valve repair. MitraClip intervention has demonstrated to improve haemodynamics and clinical outcomes in selected patients in observational and randomized studies. Preoperative pulmonary hypertension (PH) is known to affect prognosis in patients undergoing surgical mitral valve intervention. The aim of the present review is to discuss the available literature focused on the haemodynamic and clinical effects of MitraClip in patients with severe MR and PH.
    MeSH term(s) Cardiac Catheterization/adverse effects ; Heart Valve Prosthesis Implantation/adverse effects ; Hemodynamics ; Humans ; Hypertension, Pulmonary/diagnostic imaging ; Mitral Valve/diagnostic imaging ; Mitral Valve/surgery ; Mitral Valve Insufficiency/diagnostic imaging ; Mitral Valve Insufficiency/surgery ; Prognosis ; Treatment Outcome
    Language English
    Publishing date 2021-04-01
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2108910-3
    ISSN 1530-6550
    ISSN 1530-6550
    DOI 10.31083/j.rcm.2021.01.214
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top